Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Neuroendocrine Tumor Treatment Market Expected To Grow In Terms Of Size?

In the past few years, the neuroendocrine tumor treatment market has expanded at an accelerated pace. The market, which will surge from $2.17 billion in 2024 to $2.39 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 10.4%. The market’s growth during the historic period can be ascribed to factors such as enhanced clinical research and comprehension, raising awareness and education, special medical knowledge, advancements in radiation therapy, and strengthening supportive care services.

Expectations are high for the neuroendocrine tumor treatment market to witness accelerated growth in the upcoming years, expanding to a substantial $3.59 billion by 2029. This progress stems from a notable compound annual growth rate (CAGR) of 10.6%. The causes of this bolstered growth over the prediction period can be credited to improvements in precision medicine, breakthroughs in immunotherapy, the adoption of less invasive procedures, escalating incidence rates, and the rise of telemedicine and remote care. Forecasts for this period also indicate key market trends such as advancements in diagnostic technology, peptide receptor radionuclide therapy (PRRT) developments, the role of nanotechnology in drug delivery, the emergence of radiopharmaceuticals, and multidisciplinary cooperation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12248&type=smp

Which Key Factors Are Fueling Growth In The Neuroendocrine Tumor Treatment Market?

The increase in neuroendocrine tumors is anticipated to drive the neuroendocrine tumor treatment market’s expansion. Neuroendocrine tumors (NETs) are a type of uncommon tumor that arises from neuroendocrine cells. Treatment of NETs is crucial for their eradication and is typically aimed at symptom management, controlling tumor proliferation, and eradicating tumor cells via radiation therapy. For example, per the data released by the American Society of Clinical Oncology (ASCO), a professional organization based in the US, in March 2023, over 12,000 individuals are diagnosed with NETs annually in the US, with an estimated 171,000 people living with this condition as of 2023. Moreover, as per Cancer Australia, a cancer control organization from Australia, 5,437 individuals were diagnosed with NETs in 2022, constituting 3.4% of all new diagnoses in the same year. Thus, the rising incidence of neuroendocrine tumors is fueling the expansion of the neuroendocrine tumor treatment market.

How Is The Neuroendocrine Tumor Treatment Market Categorized Across Applications And Types?

The neuroendocrine tumor treatmentmarket covered in this report is segmented –

1) By Product: Somatostatin Analogs (SSAs); Targeted Therapy; Chemotherapy; Others Products

2) By Indication: Lungs; Pancreas; Gastrointestinal; Others Indications

3) By End-Users: Hospitals; Oncology Centers; Other End-Users

Subsegments:

1) By Somatostatin Analogs (SSAs): Octreotide; Lanreotide

2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Peptide Receptor Radionuclide Therapy (PRRT)

3) By Chemotherapy: Traditional Chemotherapy Agents; Combination Chemotherapy Regimens

4) By Other Products: Immunotherapy; Supportive Care Medications

How Are Industry Trends Steering The Expansion Of The Neuroendocrine Tumor Treatment Market?

One leading trend taking off in the neuroendocrine tumor treatment market is the clinical development of drugs for treatment. Key players in this market are focusing on creating new therapies to maintain their market standing. For example, Viewpoint Molecular Targeting, Inc., a pharmaceutical company based in the U.S., reported in October 2022 that the U.S. Food and Drug Administration (FDA), a U.S. federal agency, had assigned a fast-track status for their development of [212Pb] VMT-α-NET for patients with SSTR2-positive unresectable or metastatic neuroendocrine tumors (NETs). VMT-α-NET is a targeted alpha-particle therapy (TAT) specifically created to destroy cancer cells that selectively express somatostatin receptors. This fast-track status from the FDA is designed to hasten the development and evaluation of [212Pb] VMT-α-NET in the treatment of NETs. This status is awarded to medications that may potentially cause a significant improvement in the safety or effectiveness of a treatment for a serious condition.

Which Firms Are Making The Biggest Impact In The Neuroendocrine Tumor Treatment Market?

Major companies operating in the neuroendocrine tumor treatment market include Pfizer Inc., F Hoffmann-La Roche AG, Abbvie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca, Takeda Pharmaceutical, Eli Lilly And Company, Amgen Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Servier, Teva Pharmaceutical Industries Ltd., Ipsen Pharma SAS, Exelixis Inc., Advanced Accelerator Applications SA, Hutchison Medipharma Ltd., Tarveda Therapeutics, GlycoMira Therapeutics Inc, AVEO Pharmaceuticals Inc., Progenics Pharmaceuticals Inc., Callisto Pharmaceuticals Pvt Ltd., Chiasma Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/neuroendocrine-tumor-treatment-global-market-report

Which Region Holds The Greatest Opportunity For Neuroendocrine Tumor Treatment Market Expansion?

North America was the largest region in the neuroendocrine tumor treatment market in 2024. The regions covered in the neuroendocrine tumor treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12248&type=smp

Browse Through More Reports Similar to the Global Neuroendocrine Tumor Treatment Market 2025, By The Business Research Company

Food Automation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/food-automation-global-market-report

Sorting Machines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sorting-machines-global-market-report

Filling Machines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/filling-machines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model